Aminoglutethimide Drug Interactions
Currently displaying a list of 264 drugs known to interact with aminoglutethimide.
- 9 major drug interactions
- 232 moderate drug interactions
- 23 minor drug interactions
Medications known to interact with aminoglutethimide
Note: Showing generic names only.
A
- abemaciclib
- acalabrutinib
- alfentanil
- alpelisib
- aminophylline
- amprenavir
- anisindione
- apixaban
- apremilast
- aprepitant
- aripiprazole
- armodafinil
- atazanavir
- atogepant
- atorvastatin
- avacopan
- avanafil
- avapritinib
- axitinib
B
- bedaquiline
- belumosudil
- betamethasone
- bexarotene
- boceprevir
- bortezomib
- bosutinib
- brexpiprazole
- brigatinib
- bromocriptine
- budesonide
- buprenorphine
- buspirone
- butorphanol
C
- cabazitaxel
- cabozantinib
- capivasertib
- capmatinib
- carbamazepine
- cariprazine
- caspofungin
- ceritinib
- cevimeline
- chlorotrianisene
- chlorpropamide
- cobimetinib
- conjugated estrogens
- copanlisib
- cortisone
- crizotinib
D
- dapsone topical
- daridorexant
- darifenacin
- darolutamide
- darunavir
- dasatinib
- deflazacort
- delavirdine
- dexamethasone
- dicumarol
- digitoxin
- dihydroergotamine
- diltiazem
- docetaxel
- dolutegravir
- donepezil
- doravirine
- doxorubicin
- doxorubicin liposomal
- dronedarone
- drospirenone
- duvelisib
E
- efavirenz
- elacestrant
- elagolix
- eliglustat
- encorafenib
- enfortumab vedotin
- entrectinib
- enzalutamide
- ergonovine
- ergotamine
- erlotinib
- esterified estrogens
- estradiol
- estradiol topical
- estrone
- estropipate
- eszopiclone
- ethinyl estradiol
- etonogestrel
- etravirine
- everolimus
- exemestane
F
G
H
I
- ibrutinib
- idelalisib
- imatinib
- indinavir
- infigratinib
- irinotecan
- irinotecan liposomal
- isavuconazonium
- ivabradine
- ivacaftor
- ixabepilone
- ixazomib
L
- lapatinib
- larotrectinib
- lefamulin
- lemborexant
- lenacapavir
- leniolisib
- levobupivacaine
- levomethadyl acetate
- levonorgestrel
- lidocaine
- linagliptin
- lonafarnib
- lumateperone
- lurasidone
- lurbinectedin
M
- macimorelin
- macitentan
- maraviroc
- maribavir
- mavacamten
- medroxyprogesterone
- mefloquine
- megestrol
- methadone
- methylergonovine
- methylprednisolone
- methysergide maleate
- midostaurin
- mifepristone
- mirabegron
- mirtazapine
- mobocertinib
- modafinil
- montelukast
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pacritinib
- palbociclib
- palovarotene
- panobinostat
- pazopanib
- pemigatinib
- perampanel
- pimavanserin
- pioglitazone
- pirtobrutinib
- ponatinib
- praziquantel
- prednisolone
- prednisone
- progesterone
- progesterone topical
Q
R
- ramelteon
- ranolazine
- relugolix
- repaglinide
- repotrectinib
- ribociclib
- rilpivirine
- riociguat
- ripretinib
- ritlecitinib
- ritonavir
- rivaroxaban
- rolapitant
- rosiglitazone
- ruxolitinib
S
- saquinavir
- saxagliptin
- selpercatinib
- selumetinib
- sildenafil
- silodosin
- sirolimus
- sirolimus protein-bound
- solifenacin
- sonidegib
- sorafenib
- sotorasib
- sparsentan
- stiripentol
- sunitinib
- suvorexant
T
- tacrolimus
- tadalafil
- tamoxifen
- tasimelteon
- tazemetostat
- telaprevir
- telithromycin
- temsirolimus
- tepotinib
- theophylline
- ticagrelor
- tipranavir
- tofacitinib
- tolbutamide
- tolvaptan
- toremifene
- trabectedin
- tramadol
- triamcinolone
- tucatinib
U
V
- vemurafenib
- venetoclax
- vilazodone
- vinblastine
- vincristine
- vinorelbine
- vonoprazan
- voriconazole
- vortioxetine
W
Z
Aminoglutethimide disease interactions
There are 3 disease interactions with aminoglutethimide which include:
More about aminoglutethimide
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: adrenal corticosteroid inhibitors
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.